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Conclwon: Moderate H facilitates transthoracic defibrillation. Since TTI rose and current 
fell during H, the improved shock success must be due to a hypothermia-induced change 
in the mechanical or electrophysiologic properties of the myccardium. 
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1073-93 Performance of an Automated External Cardioverter 
Defibrillator for In-Hospital Ventricular Malignant 
Arrhythmia 
Seroio Timerman, Andre M. Bento, Luiz F. Cardoso, Miguel A. Moretti, Nabil E. Sanadl, 
Jose A. Ramires. Heart Institute (InCor) University of Sao Paula Medical School, Sao 
Paula, Brazil 
Purpose: Ventricular fibrillation (VF) and ventricular tachycardia (VT) are the major 
underlying rhythm during in-hospital cardiac arrest. For a patient in VFNT the probability 
of successful defibrillation and subsequent suwival to hospital discharge is directly and 
negatively related to the time interval between onset of the arrhythmia and delivery of the 
first shock. The data about this interval in clinical practice is heterogeneous and ~nconclu- 
sive, however the literature estimates it to be about 60 seconds in monitored units. Con- 
tinuos ECG monitoring allows identification of such arrhythmias and alert nursmg and 
medical staff. The time delay between the arrhyihmlc event and human intervention is 
still a challenge for clinical practice. 
Methods: We reported the use of an automated external cardioverter defibrillator (AECD) 
in 45 patients considered to be at higher risk for malIgnant arrhythmia for 24 to 48 hours. 
The inclusion criteria was acute coronary syndrome, cardiogemc shock and previous epi- 
sode of sudden death or malignant ventricular arrhythmia. The exclusion cnteria was the 
use of pacemaker or an implantable cardioverier defibrillator and an R-wave amplitude 
less than 0.7mV peak to peak at themonitor. 
Results: We recorded 17 episodes of VTNF in 3 patients. The median time between the 
beginning of the arrhythmia and the first defibrillation was 33.37 s (range 21 to 65 s). The 
sensibility and specificity were 100%. The success of the defibrillation was 94.11% (16/ 
17) for the first shock and 100% (l/l) for the second shock. There was no adverse event 
during the study penod and no episodes of inappropriate therapy delivery (the detection 
was accurate in all episodes sensitivity 100%). 
Conclusion: AECD was safe and effective. It presents the possibility of providing consis- 
tently rapid identification and response to ventricular malignant arrhyihmla. 
1073-94 The Potential Impact of a Fully Automated External 
Cardioverter Defibrillator in Centrally Monitored 
Hospital Units 
Hew Cusnir, Rohit Tongia. David Kavesteen, Karthik P. Sheka, Frederick Cassera. 
Hannah Scherer, Louise Valeno, Gerald Hollander, Maimonides Medical Center. 
Brooklyn, NY 
Background: Sudden Cardiac Arrest (SCA) survival decreases by 10% for each minute 
of delay in cardioversion, wth survival rates of 96% noted when defibrillation is achieved 
within 30 seconds of collapse. This has led to increasing use of semi-automated external 
defibrillators in many out-of-hospital settings. Recently, a fully automated external cardio- 
verter-defibrillator (AECD) was approved by the FDA for in-hospital use. The AECD can 
be programmed to automatically defibrillate a life threatening ventricular arrhythmia. The 
purpose of this study was to assess the potential impact of in-hospital AECDs on the crit- 
ical time to defibrillation in monitored hospital units. 
Methods: Mock codes (n=l6) were conducted using simulated ventricular fibrillation in 
various monitored units. Observers were stationed to record the time staff responded to 
the arrhythmia, and the time to shock. These times were compared to an AECD protocol 
that automatically defibrillates at an average of 36.3 seconds from onset of arrhythmia 
(ll=l8). 
Results: Staff vs AECD response time to arrhythmia (seconds) was 76.3 f 113.7 (Cl 
19.6 132.6) vs 7.6 f 0.6 (Cl 7.3 7.9). Staff vs AECD time to shock was 169.2 * 103.1 
(Cl 117.9 - 220.4) vs 36.3 * 0.7‘(CI 37.9 - 36.6). p values are < 0.0001 for differences 
between the groups. 
Defibrillation 
Conclusion: AECDs on monitored units could significantly reduce the critical time to 
defibrillation in patients with SCA. We anticipate this would translate to improved survival 
rates, with better neurologlc outcomes. 
1073-95 Immediate Defibrillation Predicts Probability of 
Defibrillation Curve Width for External Defibrillation 
Waveforms 
Oscar H. Tovar, David E. Snyder, Janice L. Jones, VA Medical Center-Georgetown 
University, Washington, DC, Philips Medical Systems, Seattle, WA 
Background: Defibrillation is either immediate (ID) or progressive, i.e. followed by extra- 
systoles before termination, but significance of ID remains unknown. Waveforms having 
large probability of success (POS) curve width are poor for defibrillation because out- 
come is uncertain over a large shock intensity range. We tested the hypothesis that 
waveforms having primarily ID at I50 (current for 50% success) have narrow POS curve 
width. Methods: POS curves were obtained in 21 isolated rabbit hearts using monopha- 
sic damped sine (MDS), and monophasic and biphasic truncated exponential (BTE) 
waveforms with large or small epicardial patches. Fibrillation and defibrillation type were 
recorded usmg monophasic action potential electrodes. Normalized POS curve width, 
defined as (160.120)/150 (NCW), and ID probability at 150 were determined. Results: 
Each waveform/electrode combmation yielded a single point on the nonalized curve 
width YS %ID curve. Probability of ID at I50 ranged from almost 0% for MDS with small 
electrodes to 100% for BTE with large electrodes. Probability of ID at 150 closely corre- 
lated with normalized curve width (R2 = 0.97, figure). Conclusion: The finding that a 
high probability of immediate defibrillation in low regions of the POS curve correlates with 
narrow defibrillation POS curves may lead to improved waveform/ electrode combina- 
tions that will enhance defibrillation success. 
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1074-96 Platelet Glycoprotein Ilb/llla Antagonists Are Beneficial 
in Patients With Acute Coronary Syndromes Who 
Undergo In-Hospital Coronary Artery Bypass Surgery 
Marco Roffi David J. Mollterno, Michael S. Lauer, Joel Reginelli. Gang Jia, Eric J. Topol, 
The Cleveland Clinic Foundation, Cleveland, OH, Unwersity Hospital. Zurich, 
Switzerland 
Background:The use of platelet glycoprotein Ilb/lla receptor antagonists (GP Ilb/llla) in 
non-ST-segmenf elevation acute coronary syndromes (ACS) is widely accepted, espe- 
cially for percutaneous coronary intervention. However, their efficacy in patients under- 
going in-hospital coronary artery bypass grafting (CABG) is not well established. 
Methods: We performed a pooled analysis of 4 large-scale, placebo-controlled, Ilb/llla 
ACS trials, namely PURSUIT, GUSTO IV, PARAGON A, and PARAGON B. and 
addressed outcomes among patients undergoing in-hospital CABG (N=3166) according 
to treatment allocation. Results Reported in the table 
Conclusions: The use of GP Ilb/llla Inhibitors among patients with ACS undergoing in- 
hospital CABG I?. associated with a benefit that persists at 6 months. 
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1074-99 Physician-Prescribing Patterns Among Patients 
Undergoing Coronary Artery Bypass Graft Surgery: 
Results From the ROSETTA-CABG Registry 
Karen OkraineC Mark J. Eisenberg, Louise Pilote. Jewish General Hospital, Montreal, 
PQ, Canada 
Background: GuIdeline statements have provided recommendations on appropriate 
medical therapy for patients with CAD and specific co-morbid conditions. Little is known 
on whether these recommendations are being followed in clinical practice in patients 
undergoing coronary artery bypass graft (CABG) surgery. Methods: We examined the 
rates of medical therapy among 255 patients who were enrolled in the Routine versus 
Selective Exercise Treadmill Testing After CABG (ROSETTA-CABG) Study, a prospec- 
tive multicenter study examining the use of functional testing after CABG at 12 clinical 
centers in 4 countries. Results: At discharge and 12.months. rates of aspirin were 92% 
and 66%. Anti-lipid treatment was low at discharge (56%) but increased by 12.months 
(78%). eblocker use was high at discharge (72%) but decreased by 12.months (65%). 
Rates of calcium antagonist use were low at both discharge and 12.months (19%,19%). 
Rates of ACE inhibitors remained stable from discharge to 12.months (30% to 38%). 
Rates of these medications among subgroups can be found in Table 1. Conclusion: 
Although physicians appear to be followng guidelInes regarding aspirin use, antl-lipid 
agents and ACE Inhibitors are under prescribed among patients known to benefit from 
them. Moreover, anti-lschemic medications are over prescribed among patients with no 
recurrent ischemia or Indication for their use. 
Endpoint 
30.Day Death 
30.Day Ml 
30.Day Death/Ml 
6.Month Death 
6-Month Ml 
6-Month Death/Ml 
Placebo 
N=l332 
5.1% 
23.3% 
26.0% 
7.0% 
27.4% 
31.2% 
GP Ilb/llla 
N=l634 
5.1% 
19.7% 
22.6% 
7.1% 
23.7% 
27.0% 
P 
0.965 
0.017 
0.035 
0.915 
0.037 
0.023 
1074-97 Troponin T Elevation Following Cardiac Surgery Is 
Associated With Increased One-Year Mortality and 
Morbidity 
Sekar Kathiresar! John B. Newell, Stephen J. Servoss, Dawn Trani, Thomas E. 
MacGillivray. Kent Lewandrowski, Elizabeth L. Lewandrowski, James L. Januui, Jr., 
Massachusetts General Hospital, Boston, MA 
Background: Serum Troponin T (TnT) elevation after cardiac surgery predicts impend- 
Ing in-hospital complications. Whether cardiac TnT predicts medium-term outcomes after 
cardiac surgery remains undefined. Methods: In a prognostic study of 224 patients 
undergoing cardiac surgery, serial blood sampling of TnT was performed at three time 
intewals: immediate postoperative, 6-12 hours. and 16-24 hours. One-war follow-w for 
adverse events including recurrent ischemia (RI), congestive heart f&we (CHF) and 
death was obtained in 97.3% of the oatients. TnT levels were loo-transformed. and 
divided into quintiles for analysis. Clinical variables including baseline demographics, as 
well es both creatine kinase MB isoenzyme (CK-MB) and TnT levels, were assessed with 
Cox-proportional hazards modeling to identity independent predictors of one-year out- 
comes. Results: A TnT level in the highest log quintile (~I.56 nglml) following cardiac 
surgery was the strongest predictor of cardiac complications at one-year, identifying 
patients at high risk for RI, CHF, and mortality, as well as composites of these endpoints 
(see Table 1). In the presence of TnT, the results of CK-MB testing added no significant 
independent prognostic information. Conclusions: Assessment of TnT after cardiac SUF 
gery may identify patients with a considerably increased risk for morbidity and mortality 
during the first year after heart surgery. 
Risk For One Year Adverse Outcomes Per Log QuintlIe TnT 
Endpoint Odds Ratio 95% Cl P value 
CHF (1x12) 33.0 6.2-130.0 <0.00005 
RI (n=l6) 3.3 1.2-9.1 0.012 
Death (n=15) 39.0 13.2-114.0 co.oooo5 
CHFlAl (n=26) 6.6 2.3-16.5 0.0004 
Death/RI (n=26) 6.4 2.4-17.5 0.0003 
DeathlRIICHF (n=34) 5.6 2.3-13.7 0.0001 
1074-98 Influence of Depression on Disease Specific Functional 
Status Recovery Following Coronary Bypass Surgery 
Mukesh Garq, Carlos Poston, John A. Spertus, Mid America Heart Institute. St. Luke’s 
Hospital, Kansas City, MO, Truman Medical Center, University of Missouri Kansas City 
School of Medicine, Kansas City, MO 
Background: Depression is known to mfluence cllnical outcome in patients with CAD. 
Little information is available on role of depression in recovery of disease specific func- 
ttonal status after CABG. Methods: This study prospectively tracked 224 patients’ func- 
tlonal status at baseline and at monthly intervals for 6 months following CABG. The 
Seattle Angina Questionnaire (SAQ) was used to assess angina frequency (AF), physical 
limitation (PL) due to angina, and disease specific quality of life (QOL). SAQ scores 
range O-100 where higher scores indicate better functioning. Baseline depression was 
assessed using the Mental Health Indexd. Results: 
Basehne variables (Age, gender distribution, EF, prior MI, prior revascularization, smok- 
ing, COPD. HTN. CHF. education, marital status, % living alone, and household income) 
were similar in the two groups. Depressed patients (n = 14) were more likely to have 
renal insufficiency (20% vs. 6%; p= .02), stroke (27% vs. 6%; p= .04). DM (53% vs. 27%; 
p= .04) and reported more economical strain (73% vs. 44% (p= ,001). Prior to CABG, 
depressed patients had more frequent angina (mean SAC? score 51+ 26 vs. 67 * 26 for 
non-depressed; p= .03) and were more physically limited compared to non-depressed 
patients (mean SAQ score 46 * 29 vs 66 + 25; p= ,006). Six months after CABG 
depressed patients had substantial improvement in angina frequency and physical limita- 
tion from angina, to a level comparable to non-depressed patients (mean SAQ AF score 
93 f 14 “s 93 * 12; p= .96, and mean SAQ PL score = 72 * 23 “s 76 * 22; p= .54). QOL 
was similar in both groups at baseline (mean SAQ score= 47 * 29 for depressed and 54 
+ 22 for non-depressed; p= .39). and improved similarly in both depressed and non- 
depressed patients (6 months mean SAQ score 64 t 16 vs. 84 * 17; p= .69). Conclu- 
sion: Although at presentation for CABG, depressed patients have more frequent angina 
and are more physically limited compared to non-depressed patients, 6 months following 
CABG they achieve substantial benefit to a level comparable to non-depressed patients. 
Baseline C!OL IImitation from angina and improvement following CABG are also similar in 
both groups. 
Rates of Medical Therapy Among Subset of Patlents post-CABG (N=255). 
Aspirin 
Prior MI or Stable Angina 
Anti-Lipids 
Prior MI 
Beta-Blockers 
Prior MI, CHF or Hypertensron 
Neither 
Calcium Antagonists 
Stable Angina 
No Stable Angina 
ACE inhibitors 
Prior MI 
CHF 
Diabetes 
Discharge (%) l&months (96) 
89 
55 
75 67 
64 56 
16 
19 
39 47 
56 66 
44 49 
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810 Understanding Risk Among Patients With 
Acute Coronary Disease 
Monday, March 31, 2003, 9:15 a.m.-lo:30 a.m. 
McCormick Place, Room S104 
9:15 a.m. 
81 o-1 Neovascularization Is the Most Powerful Independent 
Predictor for Progression to Disruption in High-Risk 
Atherosclerotic Plaques 
K-Raman Purushothaman, Valentin Fuster, William N. O’Connor, Pedro R. Moreno. 
University of Kentucky, Lexington, KY 
Background: High-risk lesions AHA type IV-Va may progress to disruptlon or regress to 
fibro-calcific lesions AHA Vb-Vc. Inflammation, fibrous cap thickness (FCT) and lipid area 
are critical determinants of progression. Furthermore. neovessels (NV) nourish the 
plaque and may play a role in plaque instability. This study quantified inflammation, FCT, 
liptd area. and plaque NV in high-risk, fibro-calcific and disrupted plaques. and compared 
their statistical power to predict plaque disruption. 
Methods: Studies were performed on 262 human autopsy aortic plaques. Plaque Inflam- 
mation, defined as >25 round mononuclear cells per high power field was quantified by 
light mwoscopy. Lipid area, defined by needle-shaped cholesterol cl&s was quantified 
by computerized planimetry FCT was quantified by ocular micrometry. NV, defined as 
tubuloluminal CD-34 positive capillanes were quantified wthw the fibrous cap and at the 
base of the plaque by manual counting on immunostained SectIons. 
Results: Inflammation. lipid area and NV content were increased in high-risk and dis- 
rupted plaques (Table). NV at the base of the plaque provided the strongest independent 
predictor f r plaque disruption (Table). 
Conclusion: High-risk and disrupted plaques have increased NV in comparison to fibro- 
